Cargando…
Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
The pharmacokinetic and pharmacodynamic properties of the second-generation basal insulin glargine 300 Units/mL (Gla-300) may be of benefit in the treatment of type 1 diabetes mellitus (T1DM). Gla-300 provides a stable and sustained time-action profile, which is associated with glycaemic control and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439977/ https://www.ncbi.nlm.nih.gov/pubmed/35881330 http://dx.doi.org/10.1007/s40272-022-00520-3 |